• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Microbes Infect . SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implic

tetano

Editor, Senior Moderator
Emerg Microbes Infect


. 2020 Dec 29;1-27.
doi: 10.1080/22221751.2020.1870414. Online ahead of print.
SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species


Mehdi Moustaqil[SUP] 1 [/SUP], Emma Ollivier[SUP] 1 [/SUP], Hsin-Ping Chiu[SUP] 2 [/SUP], Sarah Van Tol[SUP] 3 [/SUP], Paulina Rudolffi-Soto[SUP] 1 [/SUP], Christian Stevens[SUP] 2 [/SUP], Akshay Bhumkar[SUP] 1 [/SUP], Dominic J B Hunter[SUP] 1 4 [/SUP], Alexander N Freiberg[SUP] 5 [/SUP], David Jacques[SUP] 1 [/SUP], Benhur Lee[SUP] 2 [/SUP], Emma Sierecki[SUP] 1 [/SUP], Yann Gambin[SUP] 1 [/SUP]



Affiliations

Abstract

The genome of SARS-CoV-2 encodes two viral proteases (NSP3/ papain-like protease and NSP5/ 3C-like protease) that are responsible for cleaving viral polyproteins during replication. NSP3 and NSP5 of SARS-CoV are also known interferon antagonists and it was shown that PLpro of SARS-CoV and SARS-CoV-2 cleave post-translational modifications on host proteins involved in anti-viral responses. Here, we discovered new functions of the NSP3 and NSP5 proteases of SARS-CoV-2, demonstrating that they could directly cleave proteins involved in the host innate immune response. We designed a fluorescent based cleavage assay to rapidly screen the protease activity of NSP3 and NSP5 on a library of 71 human innate immune proteins (HIIPs), covering most pathways involved in human innate immunity. By expressing each of these HIIPs with a genetically encoded fluorophore in a cell-free system and titrating in the recombinant protease domain of NSP3 or NSP5, we could readily detect cleavage of cognate HIIPs on SDS-page gels. We identified 3 proteins that were specifically and selectively cleaved by NSP3 or NSP5: IRF-3, and NLRP12 and TAB1, respectively. Direct cleavage of IRF3 by NSP3 could explain the blunted Type-I IFN response seen during SARS-CoV-2 infections while NSP5 mediated cleavage of NLRP12 and TAB1 point to a molecular mechanism for enhanced production of cytokines and inflammatory response observed in COVID-19 patients. Surprisingly, both NLRP12 and TAB1 have each two distinct cleavage sites. We demonstrate that in the mouse NLRP12 protein, the second recognition site is not cleaved in our in-vitro assay. We pushed this comparative alignment of IRF-3 and NLRP12 homologs and show that the lack or presence of cognate cleavage motifs in IRF-3 and NLRP12 could contribute to the presentation of disease in cats and tigers, for example. Our findings provide an explanatory framework for in-depth studies into the pathophysiology of COVID-19 and should facilitate the search or development of more effective animal models for severe COVID-19.

Keywords: Coronavirus; IRF3; Innate Immunity; NLRP12; NSP3 (PLpro); NSP5 (3CLpro); Protease activity; SARS-CoV-2; TAB1.
 
Back
Top Bottom